On the other hand, encouraging evidence about the prognostic role of both IDO1 and PD-L1 in NSCLC has been found (19), as confirmed in the current study by the correlation between the IDO1 overexpression and the high probability of death from cancer. This evidence concerns the gene IDO1 and cancer.